[
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 193",
		"product" : "AMG 193",
		"project" : "5460028.01",
		"description" : "AMG 193 Solid Tumor",
		"modality" : "SM",
		"target" : "PRMT5",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 193",
		"indication_status" : "Active",
		"end_date" : "2022-05-01"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 124",
		"product" : "AMG 124",
		"project" : "5457020.01",
		"description" : "AMG 124 MAGE B2 BiTE",
		"modality" : "HLE BiTE",
		"target" : "MAGE B2",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 124",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-02"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 407",
		"product" : "Otezla",
		"project" : "5438069.05",
		"description" : "Otezla Mild to Moderate Psoriasis",
		"modality" : "SM",
		"target" : "PDE4",
		"current_phase" : "Filing",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "apremilast",
		"indication_status" : "Active",
		"end_date" : "2022-05-02"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 420",
		"product" : "AMG 420",
		"project" : "5312019.02",
		"description" : "AMG 420 MM, BCMA BiTE",
		"modality" : "BiTE",
		"target" : "BCMA Onc",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 420",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-02"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 552",
		"product" : "bemarituzumab",
		"project" : "5465082.02",
		"description" : "AMG 552 1L Gastric Cancer (BEMA + mFOLFOX + NIVO)",
		"modality" : "mAb",
		"target" : "FGFR2b",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "bemarituzumab",
		"indication_status" : "Active",
		"end_date" : "2022-05-02"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 986",
		"product" : "AMG 986",
		"project" : "5377101.01",
		"description" : "AMG 986 - Heart Failure",
		"modality" : "SM",
		"target" : "Apelin\/APJ Agonist SM",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "",
		"generic_name" : "AMG 986",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-04"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 157",
		"product" : "TEZSPIRE",
		"project" : "5186109.02",
		"description" : "Tezepelumab Atopic Dermatitis",
		"modality" : "mAb",
		"target" : "TSLP",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "AstraZeneca\/MedImmune",
		"generic_name" : "tezepelumab",
		"indication_status" : "Transition to Discontinued",
		"end_date" : "2022-05-04"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 451",
		"product" : "rocatinlimab",
		"project" : "5472109.01",
		"description" : "AMG 451 Moderate-to-Severe Atopic Dermatitis ",
		"modality" : "mAb",
		"target" : "OX40",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "Kyowa Hakko Kirin",
		"generic_name" : "rocatinlimab",
		"indication_status" : "Active",
		"end_date" : "2022-05-05"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 757",
		"product" : "tarlatamab",
		"project" : "5392982.06",
		"description" : "AMG 757 1L SCLC, DLL3 HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "DLL3 BiTE",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "tarlatamab",
		"indication_status" : "Active",
		"end_date" : "2022-05-05"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 624",
		"product" : "AMG 624",
		"project" : "5463020.01",
		"description" : "AMG 624 NSCLC",
		"modality" : "mAb",
		"target" : "TIGIT",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 624",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-06"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 160",
		"product" : "acapatamab",
		"project" : "5414024.01",
		"description" : "AMG 160 Prostate, PSMA HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "PSMA",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "acapatamab",
		"indication_status" : "Active",
		"end_date" : "2022-05-08"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 162",
		"product" : "prolia",
		"project" : "5113062.22",
		"description" : "Prolia Pediatric OI",
		"modality" : "mAb",
		"target" : "OPG L Ab",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Bone",
		"business_partner" : "",
		"generic_name" : "denosumab",
		"indication_status" : "Active",
		"end_date" : "2022-05-09"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 596",
		"product" : "AMG 596",
		"project" : "5378037.01",
		"description" : "AMG 596 GBM",
		"modality" : "BiTE",
		"target" : "EGFRvlll",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 596",
		"indication_status" : "Transition to Discontinued",
		"end_date" : "2022-05-10"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 794",
		"product" : "AMG 794",
		"project" : "5445028.01",
		"description" : "AMG 794 - Solid Tumors",
		"modality" : "HLE BiTE",
		"target" : "CLDN6",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 794",
		"indication_status" : "Active",
		"end_date" : "2022-05-10"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 397",
		"product" : "murizatoclax",
		"project" : "5399048.01",
		"description" : "AMG 397 - AML",
		"modality" : "SM",
		"target" : "Mcl - 1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "murizatoclax",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-11"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 423",
		"product" : "omecamtiv mecarbil",
		"project" : "5201101.01",
		"description" : "Omecamtiv Mecarbil",
		"modality" : "SM",
		"target" : "Cardiac Sarcomere Activator",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "Cytokinetics,Servier",
		"generic_name" : "omecamtiv mecarbil",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-11"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 104",
		"product" : "AMG 104",
		"project" : "5475009.01",
		"description" : "AMG 104\/AZD8630 - Asthma",
		"modality" : "mAb",
		"target" : "TSLP",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "AstraZeneca\/MedImmune",
		"generic_name" : "AMG 104",
		"indication_status" : "Active",
		"end_date" : "2022-05-12"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 592",
		"product" : "efavaleukin alfa",
		"project" : "5350038.01",
		"description" : "AMG 592 Steroid Resistant cGVHD",
		"modality" : "ePrFc",
		"target" : "IL-2 Mutein",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "efavaleukin alfa",
		"indication_status" : "Active",
		"end_date" : "2022-05-12"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 397",
		"product" : "murizatoclax",
		"project" : "5399053.01",
		"description" : "AMG 397 NHL",
		"modality" : "SM",
		"target" : "Mcl - 1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "murizatoclax",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-17"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 212",
		"product" : "AMG 212",
		"project" : "5309024.01",
		"description" : "AMG 212 Prostate, PSMA BiTE",
		"modality" : "BiTE",
		"target" : "PSMA",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 212",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-17"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 330",
		"product" : "AMG 330",
		"project" : "5316048.01",
		"description" : "AMG 330 AML, CD33 BiTE",
		"modality" : "BiTE",
		"target" : "CD33",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 330",
		"indication_status" : "Transition to Discontinued",
		"end_date" : "2022-05-17"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 305",
		"product" : "AMG 305",
		"project" : "5473028.01",
		"description" : "AMG 305 Colorectal",
		"modality" : "HLE dBiTE-AND",
		"target" : "MSLN\/CDH3",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 305",
		"indication_status" : "Active",
		"end_date" : "2022-05-19"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 397",
		"product" : "murizatoclax",
		"project" : "5399019.02",
		"description" : "AMG 397 MM, MCL1 p.o.",
		"modality" : "SM",
		"target" : "Mcl - 1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "murizatoclax",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-19"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 510",
		"product" : "LUMAKRAS",
		"project" : "5407028.01",
		"description" : "LUMAKRAS 2L NSCLC Mono",
		"modality" : "SM",
		"target" : "KRAS",
		"current_phase" : "Launch",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "sotorasib",
		"indication_status" : "Active",
		"end_date" : "2022-05-23"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 570",
		"product" : "rozibafusp alfa",
		"project" : "5349984.01",
		"description" : "AMG 570 SLE",
		"modality" : "AbPep",
		"target" : "B7RP1\/BAFF",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "rozibafusp alfa",
		"indication_status" : "Active",
		"end_date" : "2022-05-23"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 145",
		"product" : "Repatha",
		"project" : "5193088.05",
		"description" : "Repatha 1x420 Auto Injector",
		"modality" : "mAb",
		"target" : "PCSK9",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "Astellas",
		"generic_name" : "evolocumab",
		"indication_status" : "Transition to Discontinued",
		"end_date" : "2022-05-23"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 420",
		"product" : "AMG 420",
		"project" : "5312019.02",
		"description" : "AMG 420 MM, BCMA BiTE",
		"modality" : "BiTE",
		"target" : "BCMA Onc",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 420",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-24"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 890",
		"product" : "olpasiran",
		"project" : "5404989.01",
		"description" : "AMG 890 ASCVD",
		"modality" : "siRNA",
		"target" : "Lp(a)",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "",
		"generic_name" : "olpasiran",
		"indication_status" : "Active",
		"end_date" : "2022-05-24"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 594",
		"product" : "AMG 594",
		"project" : "5416101.01",
		"description" : "AMG 594",
		"modality" : "SM",
		"target" : "Cardiac Troponin (CTM)",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "Cytokinetics",
		"generic_name" : "AMG 594",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-24"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 397",
		"product" : "murizatoclax",
		"project" : "5399053.01",
		"description" : "AMG 397 NHL",
		"modality" : "SM",
		"target" : "Mcl - 1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "murizatoclax",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-24"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 423",
		"product" : "omecamtiv mecarbil",
		"project" : "5201101.01",
		"description" : "Omecamtiv Mecarbil",
		"modality" : "SM",
		"target" : "Cardiac Sarcomere Activator",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "Cytokinetics,Servier",
		"generic_name" : "omecamtiv mecarbil",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-25"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 757",
		"product" : "tarlatamab",
		"project" : "5392982.06",
		"description" : "AMG 757 1L SCLC, DLL3 HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "DLL3 BiTE",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "tarlatamab",
		"indication_status" : "Active",
		"end_date" : "2022-05-25"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 552",
		"product" : "bemarituzumab",
		"project" : "5465082.01",
		"description" : "AMG 552 1L Gastric Cancer (BEMA + mFOLFOX)",
		"modality" : "mAb",
		"target" : "FGFR2b",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "bemarituzumab",
		"indication_status" : "Active",
		"end_date" : "2022-05-26"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 701",
		"product" : "pavurutamab",
		"project" : "5398019.01",
		"description" : "AMG 701 MM, BCMA HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "BCMA",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "pavurutamab",
		"indication_status" : "Active",
		"end_date" : "2022-05-26"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 757",
		"product" : "tarlatamab",
		"project" : "5392982.06",
		"description" : "AMG 757 1L SCLC, DLL3 HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "DLL3 BiTE",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "tarlatamab",
		"indication_status" : "Active",
		"end_date" : "2022-05-26"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 785",
		"product" : "EVENITY",
		"project" : "5153062.02",
		"description" : "EVENITY PMO",
		"modality" : "mAb",
		"target" : "Sclerostin",
		"current_phase" : "Launch",
		"medical_therapeutic_area" : "Bone",
		"business_partner" : "Astellas,UCB",
		"generic_name" : "romosozumab",
		"indication_status" : "Active",
		"end_date" : "2022-05-27"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 256",
		"product" : "latikafusp",
		"project" : "5421028.01",
		"description" : "AMG 256 Solid, PD1\/I:21",
		"modality" : "AbePr",
		"target" : "PD1-IL21",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "latikafusp",
		"indication_status" : "Active",
		"end_date" : "2022-05-27"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 160",
		"product" : "acapatamab",
		"project" : "5414024.01",
		"description" : "AMG 160 Prostate, PSMA HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "PSMA",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "acapatamab",
		"indication_status" : "Active",
		"end_date" : "2022-05-29"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 552",
		"product" : "bemarituzumab",
		"project" : "5465082.01",
		"description" : "AMG 552 1L Gastric Cancer (BEMA + mFOLFOX)",
		"modality" : "mAb",
		"target" : "FGFR2b",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "bemarituzumab",
		"indication_status" : "Active",
		"end_date" : "2022-05-30"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 124",
		"product" : "AMG 124",
		"project" : "5457020.01",
		"description" : "AMG 124 MAGE B2 BiTE",
		"modality" : "HLE BiTE",
		"target" : "MAGE B2",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 124",
		"indication_status" : "Discontinued",
		"end_date" : "2022-05-30"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 157",
		"product" : "TEZSPIRE",
		"project" : "5186009.01",
		"description" : "Tezepelumab Severe Asthma",
		"modality" : "mAb",
		"target" : "TSLP",
		"current_phase" : "Launch",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "AstraZeneca\/MedImmune",
		"generic_name" : "tezepelumab",
		"indication_status" : "Active",
		"end_date" : "2022-05-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 794",
		"product" : "AMG 794",
		"project" : "5445028.01",
		"description" : "AMG 794 - Solid Tumors",
		"modality" : "HLE BiTE",
		"target" : "CLDN6",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 794",
		"indication_status" : "Active",
		"end_date" : "2022-05-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 786",
		"product" : "AMG 786",
		"project" : "5458060.01",
		"description" : "AMG 786 Obesity",
		"modality" : "SM",
		"target" : "FADS1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Metabolic Disorders",
		"business_partner" : "",
		"generic_name" : "AMG 786",
		"indication_status" : "Active",
		"end_date" : "2022-05-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 890",
		"product" : "olpasiran",
		"project" : "5404989.01",
		"description" : "AMG 890 ASCVD",
		"modality" : "siRNA",
		"target" : "Lp(a)",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "",
		"generic_name" : "olpasiran",
		"indication_status" : "Active",
		"end_date" : "2022-05-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 981",
		"product" : "Kyprolis",
		"project" : "5340019.07",
		"description" : "Kyprolis CANDOR (KdD RMM)",
		"modality" : "SM",
		"target" : "proteasome 26S subunit; non-ATPase 14",
		"current_phase" : "Post-Launch",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "Ono",
		"generic_name" : "carfilzomib",
		"indication_status" : "Active",
		"end_date" : "2022-05-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 103",
		"product" : "BLINCYTO",
		"project" : "5311122.08",
		"description" : "BLINCYTO Acute Lymphoblastic Leukemia (ALL) Subcutaneous Administration",
		"modality" : "BiTE",
		"target" : "CD19",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "blinatumomab",
		"indication_status" : "Active",
		"end_date" : "2022-05-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 890",
		"product" : "olpasiran",
		"project" : "5404989.01",
		"description" : "AMG 890 ASCVD",
		"modality" : "siRNA",
		"target" : "Lp(a)",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "",
		"generic_name" : "olpasiran",
		"indication_status" : "Active",
		"end_date" : "2022-08-24"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 235",
		"product" : "AMG 235",
		"project" : "5459020.01",
		"description" : "AMG 235 (CD112R+TIGIT)",
		"modality" : "mAb",
		"target" : "CD112R+TIGIT",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 235",
		"indication_status" : "Transition to Out-License \/ Spun Off",
		"end_date" : "2022-08-25"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 212",
		"product" : "AMG 212",
		"project" : "5309020.01",
		"description" : "AMG 212 - NSCLC",
		"modality" : "BiTE",
		"target" : "PSMA",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 212",
		"indication_status" : "Discontinued",
		"end_date" : "2022-08-29"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 157",
		"product" : "TEZSPIRE",
		"project" : "5186009.01",
		"description" : "Tezepelumab Severe Asthma",
		"modality" : "mAb",
		"target" : "TSLP",
		"current_phase" : "Launch",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "AstraZeneca\/MedImmune",
		"generic_name" : "tezepelumab",
		"indication_status" : "Active",
		"end_date" : "2022-08-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 982",
		"product" : "oprozomib",
		"project" : "5341019.01",
		"description" : "Oprozomib Multiple Myeloma 3L+ Lead Indication",
		"modality" : "Pep",
		"target" : "Proteasome Inhibitor",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "Ono",
		"generic_name" : "oprozomib",
		"indication_status" : "Discontinued",
		"end_date" : "2022-08-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 673",
		"product" : "emerfetamab",
		"project" : "5387048.01",
		"description" : "AMG 673 AML, CD33 HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "CD33-HLE",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "emerfetamab",
		"indication_status" : "Discontinued",
		"end_date" : "2022-09-02"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 235",
		"product" : "AMG 235",
		"project" : "5459020.01",
		"description" : "AMG 235 (CD112R+TIGIT)",
		"modality" : "mAb",
		"target" : "CD112R+TIGIT",
		"current_phase" : "Preclinical",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 235",
		"indication_status" : "Transition to Out-License \/ Spun Off",
		"end_date" : "2022-09-05"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 397",
		"product" : "murizatoclax",
		"project" : "5399019.02",
		"description" : "AMG 397 MM, MCL1 p.o.",
		"modality" : "SM",
		"target" : "Mcl - 1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "murizatoclax",
		"indication_status" : "Discontinued",
		"end_date" : "2022-09-09"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 407",
		"product" : "Otezla",
		"project" : "5438069.01",
		"description" : "Otezla Psoriasis PSO (moderate to severe)",
		"modality" : "SM",
		"target" : "PDE4",
		"current_phase" : "Post-Launch",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "apremilast",
		"indication_status" : "Active",
		"end_date" : "2022-09-15"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 212",
		"product" : "AMG 212",
		"project" : "5309024.01",
		"description" : "AMG 212 Prostate, PSMA BiTE",
		"modality" : "BiTE",
		"target" : "PSMA",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 212",
		"indication_status" : "Discontinued",
		"end_date" : "2022-09-18"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 407",
		"product" : "Otezla",
		"project" : "5438069.03",
		"description" : "Otezla Pediatric Plaque Psoriasis",
		"modality" : "SM",
		"target" : "PDE4",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "apremilast",
		"indication_status" : "Active",
		"end_date" : "2022-09-21"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 531",
		"product" : "Nplate",
		"project" : "5137003.02",
		"description" : "Nplate 1L Aplastic Anemia",
		"modality" : "PepFc",
		"target" : "TPO-R",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "romiplostim",
		"indication_status" : "Active",
		"end_date" : "2022-09-22"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 420",
		"product" : "AMG 420",
		"project" : "5312019.02",
		"description" : "AMG 420 MM, BCMA BiTE",
		"modality" : "BiTE",
		"target" : "BCMA Onc",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 420",
		"indication_status" : "Discontinued",
		"end_date" : "2022-09-26"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 592",
		"product" : "efavaleukin alfa",
		"project" : "5350074.01",
		"description" : "AMG 592 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)",
		"modality" : "ePrFc",
		"target" : "IL-2 Mutein",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "efavaleukin alfa",
		"indication_status" : "Active",
		"end_date" : "2022-09-26"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 981",
		"product" : "Kyprolis",
		"project" : "5340019.10",
		"description" : "Kyprolis KRd (NDTE)",
		"modality" : "SM",
		"target" : "proteasome 26S subunit; non-ATPase 14",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "Ono",
		"generic_name" : "carfilzomib",
		"indication_status" : "Discontinued",
		"end_date" : "2022-09-30"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 407",
		"product" : "Otezla",
		"project" : "5438069.04",
		"description" : "Otezla Genital Psoriasis",
		"modality" : "SM",
		"target" : "PDE4",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "apremilast",
		"indication_status" : "Active",
		"end_date" : "2022-10-12"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 423",
		"product" : "omecamtiv mecarbil",
		"project" : "5201101.01",
		"description" : "Omecamtiv Mecarbil",
		"modality" : "SM",
		"target" : "Cardiac Sarcomere Activator",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "Cytokinetics,Servier",
		"generic_name" : "omecamtiv mecarbil",
		"indication_status" : "Discontinued",
		"end_date" : "2022-10-26"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 510",
		"product" : "LUMAKRAS",
		"project" : "5407028.01",
		"description" : "LUMAKRAS 2L NSCLC Mono",
		"modality" : "SM",
		"target" : "KRAS",
		"current_phase" : "Launch",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "sotorasib",
		"indication_status" : "Active",
		"end_date" : "2022-10-28"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 701",
		"product" : "pavurutamab",
		"project" : "5398019.01",
		"description" : "AMG 701 MM, BCMA HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "BCMA",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "pavurutamab",
		"indication_status" : "Active",
		"end_date" : "2022-10-31"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 673",
		"product" : "emerfetamab",
		"project" : "5387048.01",
		"description" : "AMG 673 AML, CD33 HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "CD33-HLE",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "emerfetamab",
		"indication_status" : "Discontinued",
		"end_date" : "2022-11-01"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 420",
		"product" : "AMG 420",
		"project" : "5312019.02",
		"description" : "AMG 420 MM, BCMA BiTE",
		"modality" : "BiTE",
		"target" : "BCMA Onc",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "AMG 420",
		"indication_status" : "Discontinued",
		"end_date" : "2022-11-07"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 757",
		"product" : "tarlatamab",
		"project" : "5392982.05",
		"description" : "AMG 757 2L SCLC, DLL3 HLE BiTE",
		"modality" : "HLE BiTE",
		"target" : "DLL3 BiTE",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "tarlatamab",
		"indication_status" : "Active",
		"end_date" : "2022-11-07"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 397",
		"product" : "murizatoclax",
		"project" : "5399053.01",
		"description" : "AMG 397 NHL",
		"modality" : "SM",
		"target" : "Mcl - 1",
		"current_phase" : "Phase 1",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "murizatoclax",
		"indication_status" : "Discontinued",
		"end_date" : "2022-11-08"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 592",
		"product" : "efavaleukin alfa",
		"project" : "5350074.01",
		"description" : "AMG 592 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)",
		"modality" : "ePrFc",
		"target" : "IL-2 Mutein",
		"current_phase" : "Phase 2",
		"medical_therapeutic_area" : "Inflammation",
		"business_partner" : "",
		"generic_name" : "efavaleukin alfa",
		"indication_status" : "Active",
		"end_date" : "2022-11-08"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 423",
		"product" : "omecamtiv mecarbil",
		"project" : "5201101.01",
		"description" : "Omecamtiv Mecarbil",
		"modality" : "SM",
		"target" : "Cardiac Sarcomere Activator",
		"current_phase" : "Phase 3",
		"medical_therapeutic_area" : "Cardiovascular",
		"business_partner" : "Cytokinetics,Servier",
		"generic_name" : "omecamtiv mecarbil",
		"indication_status" : "Discontinued",
		"end_date" : "2022-11-09"
	},
	{
		"product_reference_label" : "Filter Products",
		"product_id" : "AMG 103",
		"product" : "BLINCYTO",
		"project" : "5311122.05",
		"description" : "BLINCYTO Acute Lymphoblastic Leukemia (ALL) Pediatric cIV",
		"modality" : "BiTE",
		"target" : "CD19",
		"current_phase" : "Launch",
		"medical_therapeutic_area" : "Hematology\/Oncology",
		"business_partner" : "",
		"generic_name" : "blinatumomab",
		"indication_status" : "Active",
		"end_date" : "2022-11-14"
	}
]
